Evidence map›Paper›PMID 40607427›Full record

ArticleFrontiers in immunology2025

P-glycoprotein expression skews mitochondrial dye measurements in T cells.

Sophia P M Sok, Jianan Cheng, Klaudia Strucinska, Narcis I Popescu, Lihua Wu, Qiuqing Ke, William B Kiosses, David Stanford, Willard M Freeman, Satoshi Matsuzaki and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sophia P M Sok *Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Jianan Cheng *Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Klaudia StrucinskaAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Narcis I PopescuArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Lihua WuArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Qiuqing KeArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
William B KiossesDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA, United States.
David StanfordCenter for Biomedical Data Science, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Willard M FreemanGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Satoshi MatsuzakiAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Tommy L LewisAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.
Meng ZhaoArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma, OK, United States.

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI COGGESHALL, KENNETH MARK · 2004 to 2023
$56.2M
Molecular and cellular mechanisms regulating mitochondrial subpopulation dynamics and function in vivoR35GM137921 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Tommy L Lewis · 2020 to 2026
$2.7M
The role of mitochondrial regulation in cell lineage specification and functionR35GM147713 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Meng Zhao · 2022 to 2026
$2.3M
NIAID NIH HHS U19 AI062629NIGMS NIH HHS R35 GM137921NIGMS NIH HHS R35 GM147713
6 · The paper itself

Abstract

Assays to monitor metabolic parameters of immune cells at a single cell level provide efficient means to study immunometabolism. We show here that staining intensity of mitochondria targeting probes in T cells is dramatically influenced by P-glycoprotein/P-gp expression, a xenobiotic efflux pump that extrudes these fluorescent dyes. Discrepancies between MitoTracker Green FM/MTG signals and multiple dye-independent measurements are seen in CD4 T and CD8 T cell subsets and are corrected by P-gp inhibition (PSC833) during MTG staining. We further investigate invariant Natural Killer T (iNKT) cells, which express the highest level of P-glycoprotein among T cells. Using mtDNA abundance, mitochondrial volume, respiration and proteomics, we establish that iNKT cells have higher mitochondrial content and activity than CD4 T cells, opposite to what MTG signals reveal. A similar phenomenon is also seen in human PBMCs, and with TMRE, a dye indicator of mitochondrial membrane potential. Collectively, these data argue that P-glycoprotein expression is a significant confounding factor when analyzing T cells using mitochondrial specific dyes. Complementary methods are necessary to reliably assess mitochondrial features in T cells.

Indexed as

ATP Binding Cassette Transporter, Subfamily B, Member 1Fluorescent DyesMitochondriaNatural Killer T-CellsT-LymphocytesCD4-Positive T-LymphocytesHumansMembrane Potential, MitochondrialATP Binding Cassette Transporter, Subfamily B, Member 1Fluorescent Dyesmitochondriamitotrackeroxidative phosphorilationP-glycolproteinT cellsTMRE

Identifiers

PMID40607427
PMCPMC12213397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.